Vancomycin-resistant ENterococci OUtcomes Study
TITLEProspective Evaluation of Clinical Outcomes of Cancer Patients with Vancomycin-Resistant Enterococcus faecium (VRE) Bacteremia
DESCRIPTION
Prospective study in cancer patients 18 years of age and older to evaluate the outcomes of patients with Vancomycin-Resistant Enterococcus faecium (VRE) bloodstream infections (BSIs) treated with Daptomycin (DAP) to compare clinical outcomes stratifying by minimum inhibitory concentration (MIC).